Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir prophylaxis for HBV reactivation during anti-TNFα therapy (Phase 3, randomized, double-blind)
KCT0000554Phase 3Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entecavir in hepatitis B (HBV), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), juvenile idiopathic arthritis (JIA), sponsored by Seoul National University Hospital. Started Sep 2012; status: recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)rheumatoid arthritis (RA)ankylosing spondylitis (AS)psoriatic arthritis (PsA)juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on KCT0000554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000554.